{"transactions":[{"id":765943,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-05-22T20:09:49.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in full on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.42,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-26-004251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826004251/ownership.xml","form_type":"4"}},{"id":1135286,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-05-23T20:05:27.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest in full on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":10.1,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-25-003991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825003991/ownership.xml","form_type":"4"}},{"id":1433610,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2024-08-14T23:26:27.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"30,000 stock options granted upon the effectiveness of the registration statement for the issuer's initial public offering on August 12, 2024, which vest in three equal installments on the first, second, and third anniversary of the grant date, subject to the reporting person's continued service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-089792","document":"tm2421559-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089792/tm2421559-5_4seq1.xml","form_type":"4"}},{"id":2218698,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-30T22:34:43.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 28, 2023 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":20000,"derivative":{"exercise_price":1.21,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-024673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924322024673/doc4.xml","form_type":"4"}},{"id":2683364,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T22:34:27.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":12.91,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-21-021845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321021845/doc4.xml","form_type":"4"}},{"id":3116454,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T20:26:47.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 5, 2021 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":9.99,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-20-015801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320015801/doc4.xml","form_type":"4"}},{"id":3494329,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-11T21:13:25.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 7, 2020 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":13.4,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-19-016421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924319016421/doc4.xml","form_type":"4"}},{"id":3806613,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-27T20:15:51.000Z","date":"2018-09-25","kind":"grant","acquired":true,"shares":52244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on March 6, 2018."}],"balance_after":52244,"derivative":{"exercise_price":11.67,"expiration_date":"2028-09-24","underlying":"Common Stock","underlying_shares":52244},"source":{"system":"sec-edgar","filing":"0000899243-18-025421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318025421/doc4.xml","form_type":"4"}},{"id":3882367,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-06-27T20:31:17.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":246781,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Be The Match BioTherapies, LLC (\"Be the Match\"). Ms. Ronneberg is President of Be The Match and disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Be The Match BioTherapies, LLC (\"Be the Match\"). Ms. Ronneberg is President of Be The Match and disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95504},"source":{"system":"sec-edgar","filing":"0000899243-18-018334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018334/doc4.xml","form_type":"4"}},{"id":3882366,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-06-27T20:31:17.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":1287100,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Be The Match BioTherapies, LLC (\"Be the Match\"). Ms. Ronneberg is President of Be The Match and disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Be The Match BioTherapies, LLC (\"Be the Match\"). Ms. Ronneberg is President of Be The Match and disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":498107},"source":{"system":"sec-edgar","filing":"0000899243-18-018334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018334/doc4.xml","form_type":"4"}},{"id":3882365,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":44726,"kind":"person","name":"RONNEBERG AMY L","position":1,"cik":"0001380292","reported_name":"RONNEBERG AMY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T20:31:17.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":593611,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Be The Match BioTherapies, LLC (\"Be the Match\"). Ms. Ronneberg is President of Be The Match and disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Be The Match BioTherapies, LLC (\"Be the Match\"). Ms. Ronneberg is President of Be The Match and disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein, if any."}],"balance_after":593611,"source":{"system":"sec-edgar","filing":"0000899243-18-018334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018334/doc4.xml","form_type":"4"}}]}